UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017001
Receipt number R000019722
Scientific Title Metagenome analysis of otorrhea
Date of disclosure of the study information 2015/04/01
Last modified on 2021/04/04 09:18:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Metagenome analysis of otorrhea

Acronym

Metagenome analysis of otorrhea

Scientific Title

Metagenome analysis of otorrhea

Scientific Title:Acronym

Metagenome analysis of otorrhea

Region

Japan


Condition

Condition

Chronic otitis media, Acute otitis media, external otitis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the bacterial flora of otorrhea by metagenome

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Metagenome analysis of otorrhea

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with otorrhea

Key exclusion criteria

no

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shujiro
Middle name
Last name Minami

Organization

National Tokyo Medical Center

Division name

Department of otolaryngology

Zip code

152-8902

Address

2-5-1 Higashigaoka Meguroku Tokyo

TEL

03-3411-0111

Email

shujirominami@me.com


Public contact

Name of contact person

1st name Shujiro
Middle name
Last name Minami

Organization

National Tokyo Medical Center

Division name

Department of otolaryngology

Zip code

152-8902

Address

2-5-1 Higashigaoka Meguroku Tokyo

TEL

03-3411-0111

Homepage URL


Email

shujirominami@me.com


Sponsor or person

Institute

National Tokyo Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Tokyo Medical Center

Address

2-5-1 Higashigaoka Meguroku Tokyo

Tel

03-3411-0111

Email

215-rinri@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 01 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-open-bin/icdr/ctr_view.cgi?recptno=R000019722

Publication of results

Unpublished


Result

URL related to results and publications

10.1002/lary.26579

Number of participants that the trial has enrolled

155

Results

Subjects with chronic otitis media without active inflammation (dry ear) had similar middle ear microbiomes as the normal middle ears group. Subjects with chronic otitis media with active inflammation (wet ear) had a lower prevalence of Proteobacteria and a higher prevalence of Firmicutes than the normal middle ears.

Results date posted

2021 Year 04 Month 04 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Active inflammation with otorrhea was noted in 44 of 88 patients with chronic otitis media.

Participant flow

Active inflammation with otorrhea was noted in 44 of 88 patients with chronic otitis media.

Adverse events

No

Outcome measures

The variable region 4 of the 16S rRNA gene in each sample were amplified using region-specific primers adapted for the Illumina MiSeq sequencer. The sequences were subjected to local blast and classified

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2015 Year 03 Month 31 Day

Date of IRB

2015 Year 03 Month 03 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Outcome of metagenome analysis


Management information

Registered date

2015 Year 03 Month 31 Day

Last modified on

2021 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019722


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name